Takeda/Nycomed

Takeda wins auction for Nycomed

Takeda agrees to pay $14 billion for Swiss drug company Nycomed in Japan's largest-ever pharma M&A deal.
May 20, 2011

Takeda Pharmaceutical is set to buy Nycomed for €9.6 billion ($13.7 billion) in cash, in Japan’s second-largest outbound M&A deal and its largest healthcare M&A deal.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media